If you have trouble falling asleep, staying asleep, or waking up feeling rested, you’re not alone. Chronic insomnia affects nearly 1 in 10 adults, and many more experience sleep difficulties at different stages of life. Poor sleep does not just affect the night. It can impact mood, concentration, energy levels, and long-term health.
At Successful Sleep and Wellness, insomnia is treated as a medical condition that deserves time, individualized evaluation, and evidence-based care. In 2025, insomnia treatment has moved beyond trial-and-error sleep aids toward approaches that improve both sleep quality and daytime functioning.
Below is an overview of what is new in insomnia treatment and what continues to work best.
CBT-I: The Foundation of Insomnia Treatment
Cognitive Behavioral Therapy for Insomnia (CBT-I) remains the first-line treatment recommended by major medical organizations, including the American Academy of Sleep Medicine and the American College of Physicians. Unlike sleep medications, CBT-I does not rely on sedation. Instead, it targets the thoughts, behaviors, and habits that perpetuate insomnia over time.
Multiple studies show that up to 80 percent of patients experience meaningful improvement with CBT-I, and the benefits are often long-lasting. Patients frequently report not only better sleep, but also improved alertness, mood, and daytime performance.
Throughout 2025, access to CBT-I has expanded through telemedicine and digital CBT-I platforms, making effective treatment more accessible than ever. Large real-world studies, including ongoing research from Penn Medicine, continue to support CBT-I as the most reliable long-term treatment for chronic insomnia.
New Insomnia Medications and What Is Actually Different
One of the most important advances in insomnia treatment is the growing use of dual orexin receptor antagonists, often referred to as DORAs. These medications work differently from traditional sleep aids.
Rather than forcing sedation, orexin receptor antagonists reduce the brain’s wake-promoting signals, allowing sleep to occur more naturally. This approach helps preserve normal sleep architecture and may reduce next-day side effects such as grogginess or impaired concentration.
Daridorexant, one of the newer medications in this class, has been shown to:
- Shorten the time it takes to fall asleep
- Reduce nighttime awakenings
- Improve daytime alertness and overall functioning
- Carry a lower risk of dependence and rebound insomnia
These medications are increasingly considered when CBT-I alone does not provide sufficient relief. They are not appropriate for every patient and are most effective when used as part of a personalized treatment plan.
Who Newer Insomnia Treatments Are and Are Not For?
Even with newer options available, insomnia treatment is never one-size-fits-all.
Newer insomnia medications may be appropriate for:
- Adults with chronic insomnia who have not improved with CBT-I alone
- Patients with significant daytime impairment related to poor sleep
- Individuals who cannot tolerate older sleep medications
They may not be appropriate for:
- Patients with untreated sleep apnea
- Individuals with certain neurological or respiratory conditions
- Those seeking medication as a replacement for behavioral therapy
A careful clinical evaluation is essential to determine the safest and most effective approach for each individual.
Rethinking Older Sleep Medications
Clinicians are increasingly cautious about the long-term use of older sleep medications such as benzodiazepines, “Z-drugs,” and sedating antihistamines. While these medications may provide short-term relief, they are associated with side effects including next-day grogginess, cognitive impairment, falls, and dependence, particularly in older adults.
When medication is needed, safer options may include:
- Low-dose doxepin for sleep maintenance
- Melatonin or ramelteon in selected patients
- Dual Orexin receptor antagonists
Treatment decisions are increasingly individualized and based on age, medical history, daytime symptoms, and patient goals.
Why Insomnia Treatment Is Not One-Size-Fits-All
Two people with insomnia may experience sleep disruption for entirely different reasons. Common contributors include stress, circadian rhythm disturbances, medical conditions, medications, and learned sleep behaviors.
Effective insomnia treatment requires understanding the full picture, not simply prescribing a sleep aid. The most effective care today focuses on:
- Personalized assessment
- Evidence-based therapy
- Thoughtful medication use, when appropriate
- Ongoing follow-up and adjustment
This patient-centered approach allows treatment to evolve as sleep improves.
The Takeaway:
Insomnia treatment in 2026 will be more personalized, safer, and more effective than ever. CBT-I remains the cornerstone of care. Newer medications offer meaningful advances when needed. Individualized treatment plans are replacing one-size-fits-all approaches.
If insomnia is affecting your quality of life, working with a sleep medicine specialist can help you find a plan that improves both your nights and your days. If you are ready for a personalized, evidence-based approach to better sleep, schedule a consultation with Successful Sleep and Wellness.
References
1. Penn Medicine. A Better Prescription for Good Sleep. November 2025.
2. León-Barriera R, et al. Insomnia in older adults: A review of treatment options. Cleveland Clinic Journal of Medicine. 2025;92(1):43–52.
3. PubMed Central. Daridorexant: A New Dual Orexin Receptor Antagonist for Insomnia
4. MedShadow Foundation. A Safer Way to Tame Insomnia. Updated January 2026.
5. Nuwer R. New treatments to put insomnia to bed. Nature. April 2025.
6. The Guardian. NHS access to promising sleeping pill daridorexant is patchy, say doctors. September 2025.
